Trial
NCT00908219
A Study of Bevacizumab to Prevent Malignant Ascites
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Baylor College of Medicine
Collaborators
Genentech, Inc.
Condition
Malignant Ascites
Intervention
Bevacizumab
Why stopped
Accrual closed by sponsor due to lack of accrual and study progress
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-06-03